HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Effects of ropinirole on motor behavior in MPTP-treated common marmosets.

Abstract
The effects of ropinirole (4-[2-(dipropylamino)ethyl]-2-indolinone monohydrochloride), a nonergoline dopamine receptor agonist with a high affinity for native dopamine D(2)-like receptors, on Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 2.5 mg/animal in common marmosets were examined and compared to the effects of bromocriptine. Ropinirole (0.1-3 mg/kg, PO) increased motor activity dose dependently and reversed akinesia or uncoordinated movement in MPTP-treated marmosets. The activities for ropinirole were very similar to those of bromocriptine. Ropinirole had, however, several properties that differed from those of bromocriptine. Ropinirole caused a more rapid onset of anti-Parkinsonian activity compared to bromocriptine, and had a potency more than five times greater than that of bromocriptine in the improvement of motor deficits. The combination of ropinirole and L-DOPA increased the effectiveness of ropinirole or L-DOPA alone, and produced a more marked additive effect on motor activity than did bromocriptine and L-DOPA. Chronic administration of ropinirole for 21 days produced a statistically significant increase in motor activity compared to the initial administration, and akinesia scores, measured through rating the quality of movements, were also improved without obvious dyskinesia. This study suggests that ropinirole is a dopamine D(2)-like receptor agonistic drug of potential use in the treatment of Parkinson's disease.
AuthorsK Fukuzaki, T Kamenosono, K Kitazumi, R Nagata
JournalPharmacology, biochemistry, and behavior (Pharmacol Biochem Behav) Vol. 67 Issue 1 Pg. 121-9 (Sep 2000) ISSN: 0091-3057 [Print] UNITED STATES
PMID11113491 (Publication Type: Journal Article)
Chemical References
  • Antiparkinson Agents
  • Dopamine Agonists
  • Indoles
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • ropinirole
  • Bromocriptine
  • Levodopa
Topics
  • Animals
  • Antiparkinson Agents (pharmacology)
  • Bromocriptine (pharmacology)
  • Callithrix
  • Dopamine Agonists (pharmacology)
  • Female
  • Indoles (pharmacology)
  • Levodopa (pharmacology)
  • MPTP Poisoning (drug therapy)
  • Male
  • Motor Activity (drug effects)
  • Receptors, Dopamine D2 (drug effects, physiology)
  • Receptors, Dopamine D3

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD